Molecular testing at the speed of life
On the frontline of tackling COVID-19
Cue's COVID-19 test
Helping you get back to business
How Cue helpsWhat is Cue?
Cue is a connected, molecular diagnostic system
The Cue Health Monitoring System is a rapid, compact, highly portable testing platform with no compromise in performance or accuracy. It uses molecular diagnostic technology to deliver reliable results in about 20 minutes.
Who we work with
Cue is partnering with leading organizations such as BARDA, Henry Schein, Johnson & Johnson, Mayo Clinic, and the National Basketball Association to further our science and protect human health.
Newsroom
View all pressCue’s CEO Ayub Khattak joins Lisa Ling on Season 2 of Johnson & Johnson’s COVID-19 Series: The Road to a Vaccine
Read moreCue’s CEO Ayub Khattak and Andrew Ross Sorkin on Squawk Box
Read moreCue Receives $481 Million Award by DOD and HHS to Expand Domestic Production Capacity and Provide 6 Million…
Read moreCue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19…
Read moreCue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read moreCue Health Awarded $13 Million for Rapid, Portable, Point-of-Care COVID-19 Test by U.S. Department of Health and…
Read more
Applications
One system, any industry
Accessible, accurate, scalable diagnostic testing for any industry, including healthcare, government, and education.
Who we are
Meet the team at Cue
We’re on a mission to transform how we detect disease and protect human health.
Made in the USA
Designed, engineered, manufactured, and tested in San Diego
Proudly headquartered in San Diego, Cue’s state-of-the-art space includes lab, office, and production facilities.
